|
|
|
Volumn 26, Issue 4, 1999, Pages 428-438
|
|
Chemotherapy in advanced prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
ESTRAMUSTINE;
ETOPOSIDE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
SURAMIN;
VINBLASTINE;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER EPIDEMIOLOGY;
CANCER PALLIATIVE THERAPY;
CANCER SURVIVAL;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROSTATE CANCER;
SIDE EFFECT;
TUMOR GROWTH;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, HORMONAL;
CLINICAL TRIALS;
DOXORUBICIN;
ESTRAMUSTINE;
HUMANS;
LIPOSOMES;
MALE;
MITOXANTRONE;
NEOPLASMS, HORMONE-DEPENDENT;
PALLIATIVE CARE;
PROSTATIC NEOPLASMS;
SURAMIN;
|
|
EID: 0032860893
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (47)
|
|
References (50)
|
